• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Pharma Pulse 6/21/24: Improving Access to Trials Through Decentralization & Flexible Design, South Africa Runs Out of Insulin Pens & more


The latest news for pharma industry insiders.

DIA 2024: Improving Patient Access to Clinical Trials Through Decentralization and Flexible Design: Lessons from Oncology

Breakout session discusses the impact of incorporating decentralized elements into oncology clinical trials on data integrity, patient safety, and regulatory approvals.

Expert: Individualized Gender-Affirming Care and Support is Essential for LGBTQ+ Patients

For Pride Month, Pharmacy Times interviewed Olivia Buckoski, PharmD, AAHIVP, HIVPCP, clinical pharmacist, Western North Carolina Community Health Services, to discuss gender-affirming care for patients in the LGBTQ+ community, what it looks like, and the importance of catering care to the individual. This patient population often face stigma, a lack of cultural competency among providers, and discrimination; however, pharmacists and health care professionals can help by creating a supportive environment for patients.

Improve Site Experience with Data-Driven Protocol Design

Do you know what challenges are encountered by sites when operationalizing study protocols? In this webinar, learn how specific protocol design elements impact sites’ perception of burden and how this information can be used to improve site experience.

South Africa Runs Out of Insulin Pens as Global Supply Shifts to Weight-Loss Drugs

The shortage highlights a widening gulf in the standard of care for people with diabetes, most of whom live in low-income countries.

QPS Announces New Global Clinical Research Operations Leadership

QPS is pleased to announce new clinical research operations leadership. This new clinical leadership will further align the existing global medical affairs, regulatory affairs, data services, and clinical operations units with the existing successful QPS Phase I clinics. The enhanced global capabilities will help QPS satisfy the need for agility, flexibility, and speed in the quickly evolving global drug development community.

Jill Donahue, Fueling the power of purpose in pharma teams on LinkedIn

Sharing insights from interviewing hundreds of exceptional pharma leaders. Want to know what they do differently? Enjoy my short article published today in Pharmaceutical Executive

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs